• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“心率下降反应”心脏起搏治疗血管迷走性晕厥。心率下降反应研究组。

"Rate-drop response" cardiac pacing for vasovagal syncope. Rate-Drop Response Investigators Group.

作者信息

Benditt D G, Sutton R, Gammage M, Markowitz T, Gorski J, Nygaard G, Fetter J

机构信息

Department of Medicine, University of Minnesota Medical School, Minneapolis, USA.

出版信息

J Interv Card Electrophysiol. 1999 Mar;3(1):27-33. doi: 10.1023/a:1009815304770.

DOI:10.1023/a:1009815304770
PMID:10354973
Abstract

Recent reports suggest that cardiac pacing incorporating a rate-drop response algorithm is associated with a reduction in the frequency of syncopal episodes in patients with apparent cardioinhibitory vasovagal syncope. The detection portion of the algorithm employs a programmable heart rate change-time duration "window" to both identify abrupt cardiac slowing suggestive of an imminent vasovagal event and trigger "high rate" pacing. The purpose of this study was to develop recommendations for programming the rate-drop response algorithm. Pacemaker programming, symptom status, and drug therapy were assessed retrospectively in 24 patients with recurrent vasovagal syncope of sufficient severity to warrant consideration of pacemaker treatment. In the 53 +/- 19 months prior to pacing, patients had experienced an approximate syncope burden of 1.2 events/month. During follow-up of 192 +/- 160 days, syncope recurred in 4 patients (approximate syncope burden, 0.3 events/month, p < 0.05 vs. pre-pacing), and pre-syncope in 5 patients. In these patients, rate-drop response parameters were initially set based on electrocardiographic and/or tilt-table recordings, and were re-programmed at least once in 14 (58%) individuals. A 20 beat/min window height (top rate minus bottom rate), a window width of 10 beats (61% of patients), and 2 or 3 confirmation beats (79% of patients) appeared to be appropriate in most patients. Treatment intervention rate was set to > 100 beats/min in 89% of patients, with a duration of 1 to 2 min in 79%. In conclusion, a narrow range of rate-drop response parameter settings appeared to be effective for most individuals in this group of highly symptomatic patients.

摘要

最近的报告表明,采用心率下降反应算法的心脏起搏与明显心脏抑制型血管迷走性晕厥患者晕厥发作频率的降低有关。该算法的检测部分采用一个可编程的心率变化-持续时间“窗口”,以识别提示即将发生血管迷走事件的心脏突然减慢,并触发“高速率”起搏。本研究的目的是制定心率下降反应算法的编程建议。对24例复发性血管迷走性晕厥严重程度足以考虑起搏器治疗的患者进行了回顾性评估,包括起搏器编程、症状状态和药物治疗。在起搏前53±19个月期间,患者每月晕厥负担约为1.2次。在192±160天的随访期间,4例患者再次发生晕厥(晕厥负担约为每月0.3次,与起搏前相比p<0.05),5例患者发生前驱晕厥。在这些患者中,心率下降反应参数最初根据心电图和/或倾斜试验记录进行设置,14例(58%)患者至少重新编程一次。大多数患者似乎适合采用20次/分钟的窗口高度(最高心率减去最低心率)、10次心跳的窗口宽度(61%的患者)以及2次或3次确认心跳(79%的患者)。89%的患者治疗干预心率设置为>100次/分钟,79%的患者持续时间为1至2分钟。总之,在这组症状严重的患者中,大多数个体采用较窄范围的心率下降反应参数设置似乎是有效的。

相似文献

1
"Rate-drop response" cardiac pacing for vasovagal syncope. Rate-Drop Response Investigators Group.“心率下降反应”心脏起搏治疗血管迷走性晕厥。心率下降反应研究组。
J Interv Card Electrophysiol. 1999 Mar;3(1):27-33. doi: 10.1023/a:1009815304770.
2
Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group.Thera DR 心率下降反应起搏算法在颈动脉窦综合征和血管迷走性晕厥中的临床经验。国际心率下降研究组。
Pacing Clin Electrophysiol. 1997 Mar;20(3 Pt 2):832-9. doi: 10.1111/j.1540-8159.1997.tb03916.x.
3
DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope.具有心率下降反应功能的双腔按需起搏(DDD)与具有心率滞后起搏功能的双腔抑制型起搏(DDI)用于心脏抑制型血管迷走性晕厥的比较
Pacing Clin Electrophysiol. 1998 Nov;21(11 Pt 2):2178-81. doi: 10.1111/j.1540-8159.1998.tb01148.x.
4
Clinical experience of a new rate drop response algorithm in the treatment of vasovagal and carotid sinus syncope.一种新型心率下降反应算法治疗血管迷走性晕厥和颈动脉窦晕厥的临床经验
Europace. 2000 Jul;2(3):245-50. doi: 10.1053/eupc.2000.0107.
5
Does cardiac pacing reduce syncopal recurrences in cardioinhibitory vasovagal syncope patients selected with head-up tilt test? Analysis of a 5-year follow-up database.心脏起搏是否能减少直立倾斜试验选择的心脏抑制型血管迷走性晕厥患者的晕厥复发?一项 5 年随访数据库的分析。
Int J Cardiol. 2018 Nov 1;270:149-153. doi: 10.1016/j.ijcard.2018.06.063. Epub 2018 Jun 20.
6
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study.双腔闭环刺激对倾斜诱导血管迷走性心抑制性晕厥健康患者晕厥复发的影响:前瞻性、随机、单盲、交叉研究。
Heart. 2013 Nov;99(21):1609-13. doi: 10.1136/heartjnl-2013-303878. Epub 2013 May 30.
7
Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.双腔起搏治疗神经介导的倾斜试验阳性心脏抑制型晕厥:起搏器治疗与非治疗对照:一项多中心随机研究。血管迷走性晕厥国际研究(VASIS)调查组
Circulation. 2000 Jul 18;102(3):294-9. doi: 10.1161/01.cir.102.3.294.
8
A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).一项关于永久性心脏起搏治疗复发性倾斜诱发血管迷走性晕厥的随机、双盲、安慰剂对照研究。血管迷走性晕厥与起搏试验(SYNPACE)。
Eur Heart J. 2004 Oct;25(19):1741-8. doi: 10.1016/j.ehj.2004.06.031.
9
A systematic review on recurrent cardioinhibitory vasovagal syncope: Does pacing therapy break the fall?复发性心脏抑制性血管迷走性晕厥的系统评价:起搏治疗能否打破这种下降趋势?
Pacing Clin Electrophysiol. 2019 Oct;42(10):1400-1407. doi: 10.1111/pace.13790. Epub 2019 Sep 10.
10
Closed-loop cardiac pacing vs. conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up.闭环心脏起搏与传统双腔起搏与专门的感知和起搏算法在难治性血管迷走性晕厥患者中的晕厥预防:长期随访结果。
Europace. 2012 Jul;14(7):1038-43. doi: 10.1093/europace/eur419. Epub 2012 Jan 13.

引用本文的文献

1
Carotid Sinus Syndrome Associated with Carcinoma Ex-Pleomorphic Adenoma: What Is the Role of Artificial Cardiac Stimulation?与多形性腺瘤恶变相关的颈动脉窦综合征:人工心脏刺激的作用是什么?
Arq Bras Cardiol. 2024 Aug 12;121(7):e20240026. doi: 10.36660/abc.20240026. eCollection 2024.
2
Pacing Therapies for Vasovagal Syncope.血管迷走性晕厥的起搏治疗
J Atr Fibrillation. 2020 Jun 30;13(1):2406. doi: 10.4022/jafib.2406. eCollection 2020 Jun-Jul.
3
Pacing for Vasovagal Syncope.血管迷走性晕厥的起搏治疗

本文引用的文献

1
Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope.具有自动心率下降感知功能的双腔起搏对复发性神经介导性晕厥的影响。
Am J Cardiol. 1998 Jan 15;81(2):158-62. doi: 10.1016/s0002-9149(97)00891-6.
2
North American Vasovagal Pacemaker Study: study design and organization.
Pacing Clin Electrophysiol. 1997 Mar;20(3 Pt 2):844-8. doi: 10.1111/j.1540-8159.1997.tb03919.x.
3
Tilt table testing for assessing syncope. American College of Cardiology.用于评估晕厥的倾斜试验。美国心脏病学会。
Arrhythm Electrophysiol Rev. 2018 Jun;7(2):95-102. doi: 10.15420/aer.2018.22.2.
4
New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope.神经介导性反射(神经心源性)晕厥的治疗与预防新方法。
Curr Cardiol Rep. 2004 Sep;6(5):385-90. doi: 10.1007/s11886-004-0042-7.
5
Neurocardiogenic syncope: aetiology and management.神经心源性晕厥:病因与管理
Drugs. 2001;61(10):1415-23. doi: 10.2165/00003495-200161100-00005.
6
Bradyarrhythmias.
Curr Treat Options Cardiovasc Med. 2001 Aug;3(4):291-298. doi: 10.1007/s11936-001-0091-9.
7
Determining the optimal pacing intervention rate for vasovagal syncope.
J Interv Card Electrophysiol. 2000 Dec;4(4):585-9. doi: 10.1023/a:1026509430078.
8
Emerging indications for permanent pacing.永久性起搏的新适应证
Curr Cardiol Rep. 2000 Jul;2(4):353-60. doi: 10.1007/s11886-000-0093-3.
J Am Coll Cardiol. 1996 Jul;28(1):263-75. doi: 10.1016/0735-1097(96)00236-7.
4
Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.心脏起搏与药物治疗在伴有心动过缓或心搏停止的神经心源性(血管迷走性)晕厥治疗中的比较。
N Engl J Med. 1993 Apr 15;328(15):1085-90. doi: 10.1056/NEJM199304153281504.
5
A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt.一项关于静脉注射和口服丙吡胺预防头高位倾斜诱发的神经介导性晕厥的安慰剂对照试验。
J Am Coll Cardiol. 1993 Dec;22(7):1843-8. doi: 10.1016/0735-1097(93)90767-u.
6
Neurally mediated syncope with an update on indications and usefulness of head-upright tilt table testing and pharmacologic therapy.
Curr Opin Cardiol. 1994 Jan;9(1):53-64. doi: 10.1097/00001573-199401000-00007.
7
Permanent pacing for cardioinhibitory malignant vasovagal syndrome.心脏抑制型恶性血管迷走性综合征的永久性起搏治疗
Br Heart J. 1994 Mar;71(3):274-81. doi: 10.1136/hrt.71.3.274.
8
Cardiac pacing for prevention of recurrent vasovagal syncope.心脏起搏用于预防血管迷走性晕厥复发。
Ann Intern Med. 1995 Feb 1;122(3):204-9. doi: 10.7326/0003-4819-122-3-199502010-00008.
9
Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope.盐酸氟西汀预防难治性直立性倾斜试验诱发晕厥的有效性
Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 1):458-64. doi: 10.1111/j.1540-8159.1993.tb01608.x.
10
Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results.口服阿替洛尔治疗不明原因晕厥且直立倾斜试验结果阳性患者的随机双盲安慰剂对照试验
Am Heart J. 1995 Dec;130(6):1250-3. doi: 10.1016/0002-8703(95)90150-7.